Antiproliferative Effect of Lapatinib in HER2-Positive and HER2-Negative/HER3-High Breast Cancer: Results of the Presurgical Randomized MAPLE Trial (CRUK E/06/039). (Q53004084)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Antiproliferative Effect of Lapatinib in HER2-Positive and HER2-Negative/HER3-High Breast Cancer: Results of the Presurgical Randomized MAPLE Trial (CRUK E/06/039). |
scientific article |
Statements
Antiproliferative Effect of Lapatinib in HER2-Positive and HER2-Negative/HER3-High Breast Cancer: Results of the Presurgical Randomized MAPLE Trial (CRUK E/06/039) (English)
Abigail Evans
Stephen R D Johnston
Roger A'Hern
Rashmita Sahoo
Simone Detre
Benjamin P Haynes
Margaret Hills
Catherine Harper-Wynne
Nigel Bundred
Gill Coombes
Ian Smith
14 November 2014